Cancer Risk Forces Recall of Weight-Loss Drug Belviq
Share!
Claims Journal - Feb 14, 2020
Weight-loss drug Belviq will be withdrawn from the U.S. market at the request of the Food and Drug Administration, after research tied it to increased rates of cancer. Belviq came on the market in the U.S. in 2012 and is …...
Recommended Articles